-
1
-
-
0026099914
-
A Potent Non-Peptide Antagonist of the Substance P (NK1) Receptor
-
Snider, R. M.; Constantine, J. W.; Lowe, J. A.; Longo, K. P.; Lebel, W. S.; Woody, H. A.; Drozda, S. E.; Desai, M. C.; Vinick, F. J.; Spencer, R. W.; Hess, H. J. A Potent Non-Peptide Antagonist of the Substance P (NK1) Receptor. Science 1991, 251, 435-437.
-
(1991)
Science
, vol.251
, pp. 435-437
-
-
Snider, R.M.1
Constantine, J.W.2
Lowe, J.A.3
Longo, K.P.4
Lebel, W.S.5
Woody, H.A.6
Drozda, S.E.7
Desai, M.C.8
Vinick, F.J.9
Spencer, R.W.10
Hess, H.J.11
-
2
-
-
0027048485
-
Discovery of a Potent Substance P Antagonist: Recognition of the Key Molecular Determinant
-
(a) Desai, M. C.; Lefkowitz, S. L.; Thadeio, P. F.; Longo, K. P.; Snider, R. M. Discovery of a Potent Substance P Antagonist: Recognition of the Key Molecular Determinant. J. Med. Chem. 1992, 35, 4911-4913.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 4911-4913
-
-
Desai, M.C.1
Lefkowitz, S.L.2
Thadeio, P.F.3
Longo, K.P.4
Snider, R.M.5
-
3
-
-
0027237031
-
CP-99,994, A Nonpeptide Antagonist of the Tachykinin NK1 Receptor
-
(b) McLean, S.; Snider, R. M.; Desai, M. C.; Rosen, T.; Bryce, D. K.; Longo, K. P.; Schmidt, A. W.; Heym, J. CP-99,994, A Nonpeptide Antagonist of the Tachykinin NK1 Receptor. Regulat. Pept. 1993, 46, 329-331.
-
(1993)
Regulat. Pept.
, vol.46
, pp. 329-331
-
-
McLean, S.1
Snider, R.M.2
Desai, M.C.3
Rosen, T.4
Bryce, D.K.5
Longo, K.P.6
Schmidt, A.W.7
Heym, J.8
-
4
-
-
0027420750
-
Pharmacology of CP-99,994; A Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor
-
(c) McLean, S.; Ganong, A.; Seymour, P. A.; Snider, R. M.; Desai, M. C.; Rosen, T.; Bryce, D. K.; Longo, K. P.; Reynolds, L. S.; Robinson, G.; Schmidt, A. W.; Siok, C.; Heym, J. Pharmacology of CP-99,994; A Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor. J. Pharmacol. Exp. Ther. 1993, 267, 472-479.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.267
, pp. 472-479
-
-
McLean, S.1
Ganong, A.2
Seymour, P.A.3
Snider, R.M.4
Desai, M.C.5
Rosen, T.6
Bryce, D.K.7
Longo, K.P.8
Reynolds, L.S.9
Robinson, G.10
Schmidt, A.W.11
Siok, C.12
Heym, J.13
-
5
-
-
0029658344
-
Nonpeptide tachykinin antagonists: Medicinal Chemistry and molecular biology
-
(d) Lowe, J. A., III. Nonpeptide tachykinin antagonists: Medicinal Chemistry and molecular biology. Med. Res. Rev. 1996, 16 (6), 527-545.
-
(1996)
Med. Res. Rev.
, vol.16
, Issue.6
, pp. 527-545
-
-
Lowe III, J.A.1
-
7
-
-
0029585287
-
Discovery of an Orally Bioavailable NK-1 Receptor Antagonist, (2S, 3S)-(2-Methoxy-5-tetrazol-l-ylbenzyl)(2-phenylpiperidm-3-yl)amine (GR203040), with Potent Antiemetic Activity
-
Ward, P.; Armour, D. R.; Bays, D. E.; Evans, B.; Giblin, G. M. P.; Heron, N.; Hubbard, T.; Liang, K.; Middlemiss, D.; Mordaunt, J.; Naylor, A.; Pegg, N. A.; Vinader, V.; Watson, S. P.; Bountra, C.; Evans, D. C. Discovery of an Orally Bioavailable NK-1 Receptor Antagonist, (2S, 3S)-(2-Methoxy-5-tetrazol-l-ylbenzyl)(2-phenylpiperidm-3-yl)amine (GR203040), with Potent Antiemetic Activity. J. Med. Chem. 1995, 38, 4985-4992.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 4985-4992
-
-
Ward, P.1
Armour, D.R.2
Bays, D.E.3
Evans, B.4
Giblin, G.M.P.5
Heron, N.6
Hubbard, T.7
Liang, K.8
Middlemiss, D.9
Mordaunt, J.10
Naylor, A.11
Pegg, N.A.12
Vinader, V.13
Watson, S.P.14
Bountra, C.15
Evans, D.C.16
-
9
-
-
8944260413
-
1 Antagonists
-
1 Antagonists. J. Med. Chem. 1996, 39, 2907-2914.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 2907-2914
-
-
Ladduwahetty, T.1
Baker, R.2
Cascieri, M.A.3
Chambers, M.S.4
Haworth, K.5
Keown, L.6
MacIntyre, D.E.7
Metzger, J.M.8
Owen, S.9
Rycroft, W.10
Sadowski, S.11
Seward, E.M.12
Shepheard, S.13
Swain, C.J.14
Tattersall, F.D.15
Williamson, D.16
Hargreaves, R.J.17
-
10
-
-
0029878786
-
2-(S)-3,5-bis(trifluoromethyl)benzyloxy-3-(S)-phenyl-4-5-(3-oxo-1,2,4- triazolo)methylmorpholine, A Potent, Orally Active, Morpholine-Based Human NK-1 Receptor Antagonist
-
Hale, J. J.; Mills, S. G.; MacCoss, M.; Shah, S. K.; Qi, H.; Mathre, D. J.; Cascieri, M. A.; Sadowski, S.; Strader, C. D.; MacIntyre, D. E.; Metzger, J. M. (2-(S)-(3,5-bis(trifluoromethyl)benzyloxy-3-(S)-phenyl-4-(5-(3-oxo-1,2,4- triazolo)methylmorpholine, A Potent, Orally Active, Morpholine-Based Human NK-1 Receptor Antagonist. J. Med. Chem. 1996, 39, 1760-1762.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1760-1762
-
-
Hale, J.J.1
Mills, S.G.2
MacCoss, M.3
Shah, S.K.4
Qi, H.5
Mathre, D.J.6
Cascieri, M.A.7
Sadowski, S.8
Strader, C.D.9
MacIntyre, D.E.10
Metzger, J.M.11
-
11
-
-
0027214178
-
N-Acyl Tryptophan Benzyl Esters: Potent Substance P Antagonists
-
MacLeod, A. M.; Merchant, K. J.; Brookfield, F.; Lewis, R.; Kelleher, F.; Stevenson, G.; Owens, A.; Swain, C. J.; Baker, R.; Cascieri, M. A.; Sadowski, S.; Ber, E.; MacIntyre, D. E.; Metzger, J.; Ball, R. N-Acyl Tryptophan Benzyl Esters: Potent Substance P Antagonists. J. Med. Chem. 1993, 36, 2044-2045.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 2044-2045
-
-
MacLeod, A.M.1
Merchant, K.J.2
Brookfield, F.3
Lewis, R.4
Kelleher, F.5
Stevenson, G.6
Owens, A.7
Swain, C.J.8
Baker, R.9
Cascieri, M.A.10
Sadowski, S.11
Ber, E.12
MacIntyre, D.E.13
Metzger, J.14
Ball, R.15
-
12
-
-
0344447315
-
1 Receptor
-
1 Receptor. Neuropeptides 1993, 24, 233.
-
(1993)
Neuropeptides
, vol.24
, pp. 233
-
-
Oury-Donat, F.1
Lefevre, I.A.2
Gautier, T.3
Edmonds-Alt, X.4
Le Fur, G.5
Soubrie, P.6
-
13
-
-
0026503927
-
Differential activation of intracelluar effectors by two isoforms of human neurokinin-1 receptor
-
(a) Fong, T. M.; Anderson, S. A.; Yu, H.; Huang, R. R. C.; Strader, C. D. Differential activation of intracelluar effectors by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 1992, 41, 24-30.
-
(1992)
Mol. Pharmacol.
, vol.41
, pp. 24-30
-
-
Fong, T.M.1
Anderson, S.A.2
Yu, H.3
Huang, R.R.C.4
Strader, C.D.5
-
14
-
-
0025997478
-
Molecular cloning, structural characterisation and functional expression of the human Substance P receptor
-
(b) Takeda, Y.; Chou, K. B.; Takeda, J.; Sachais, B. S.; Krause, J. E. Molecular cloning, structural characterisation and functional expression of the human Substance P receptor. Biochem. Biophys. Res. Commun. 1991, 179, 1232-1240.
-
(1991)
Biochem. Biophys. Res. Commun.
, vol.179
, pp. 1232-1240
-
-
Takeda, Y.1
Chou, K.B.2
Takeda, J.3
Sachais, B.S.4
Krause, J.E.5
-
15
-
-
0025376074
-
Neurogenic Inflamation in Airways and its Modulation
-
Barnes, P. J. Neurogenic Inflamation in Airways and its Modulation. Arch. Int. Pharmacodyn. 1990, 303, 67-82. See also: Lotz, M.; Vaughan, J. H.; Carson, D. A. Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes. Science 1988, 241, 1218-1221.
-
(1990)
Arch. Int. Pharmacodyn.
, vol.303
, pp. 67-82
-
-
Barnes, P.J.1
-
16
-
-
0023753067
-
Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes
-
Barnes, P. J. Neurogenic Inflamation in Airways and its Modulation. Arch. Int. Pharmacodyn. 1990, 303, 67-82. See also: Lotz, M.; Vaughan, J. H.; Carson, D. A. Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes. Science 1988, 241, 1218-1221.
-
(1988)
Science
, vol.241
, pp. 1218-1221
-
-
Lotz, M.1
Vaughan, J.H.2
Carson, D.A.3
-
17
-
-
0023851663
-
Effect of a Tachykinin Antagonist on a Nociceptive Reflex in the Isolated Spinal Cord-Tail preparation of the Newborn Rat
-
Otsuka, M.; Yanigasawa, M. Effect of a Tachykinin Antagonist on a Nociceptive Reflex in the Isolated Spinal Cord-Tail preparation of the Newborn Rat. J. Physiol. (London) 1988, 395, 255-270.
-
(1988)
J. Physiol. (London)
, vol.395
, pp. 255-270
-
-
Otsuka, M.1
Yanigasawa, M.2
-
18
-
-
0016633405
-
Effect of Substance P on Blood Flow in Canine Adipose Tissue and Skeletal Muscle
-
Pernow, B.; Rosell, S. Effect of Substance P on Blood Flow in Canine Adipose Tissue and Skeletal Muscle. Acta Physiol. Scand. 1975, 93, 139-141.
-
(1975)
Acta Physiol. Scand.
, vol.93
, pp. 139-141
-
-
Pernow, B.1
Rosell, S.2
-
19
-
-
0022578896
-
Asthma as an Axon Reflex
-
Barnes, P. J. Asthma as an Axon Reflex. Lancet 1986, 242-244.
-
(1986)
Lancet
, pp. 242-244
-
-
Barnes, P.J.1
-
20
-
-
0024354119
-
Substance P Primes Human Neutrophil Activation: A Mechanism for Neurological Regulation of Inflammation
-
Perianin, A.; Snyderman, R.; Malfroy, B. Substance P Primes Human Neutrophil Activation: A Mechanism for Neurological Regulation of Inflammation. Biochem. Biophys. Res. Commun. 1989, 161, 520-524.
-
(1989)
Biochem. Biophys. Res. Commun.
, vol.161
, pp. 520-524
-
-
Perianin, A.1
Snyderman, R.2
Malfroy, B.3
-
21
-
-
0027339837
-
The Non-peptide Neurokinini Receptor Antagonist RP 76580 Blocks Neurogenic Plasma Extravasation in the Dura Mater of Rats
-
(a) Shepheard, S. L.; Williamson, D. W.; Hill, R. G.; Hargreaves, R. J. The Non-peptide Neurokinini Receptor Antagonist RP 76580 Blocks Neurogenic Plasma Extravasation in the Dura Mater of Rats. Br. J. Pharmacol 1993, 108, 11-12.
-
(1993)
Br. J. Pharmacol
, vol.108
, pp. 11-12
-
-
Shepheard, S.L.1
Williamson, D.W.2
Hill, R.G.3
Hargreaves, R.J.4
-
22
-
-
0028941078
-
1 Antagonist CP-99,994 on Plasma Extravasation in Dura Mater and c-fos mRNA Expression in Trigeminal Caudalis of Rats
-
1 Antagonist CP-99,994 on Plasma Extravasation in Dura Mater and c-fos mRNA Expression in Trigeminal Caudalis of Rats. Neuropharmacology 1995, 34 (3), 255-261.
-
(1995)
Neuropharmacology
, vol.34
, Issue.3
, pp. 255-261
-
-
Shepheard, S.L.1
Williamson, D.W.2
Williams, J.3
Hill, R.G.4
Hargreaves, R.J.5
-
24
-
-
0029065938
-
1 Receptor
-
1 Receptor. Br. J. Pharmacol. 1995, 115, 84-94.
-
(1995)
Br. J. Pharmacol.
, vol.115
, pp. 84-94
-
-
Watson, J.W.1
Gonsalves, S.F.2
Fossa, A.A.3
McLean, S.4
Seeger, T.5
Obach, S.6
Andrews, P.L.R.7
-
25
-
-
0002682811
-
1 Receptor Antagonists are Centrally Mediated
-
1 Receptor Antagonists are Centrally Mediated. Can. J. Physiol. Pharmacol. 1994, 72 (Suppl. 2), 45.
-
(1994)
Can. J. Physiol. Pharmacol.
, vol.72
, Issue.SUPPL. 2
, pp. 45
-
-
Hargreaves, R.J.1
Tattersall, F.D.2
Rycroft, W.3
Woodford, K.4
Ladduwahetty, T.5
Keown, L.6
Merchant, K.7
Swain, C.8
MacLeod, A.9
Baker, R.10
Francis, B.11
Burns, D.12
Ber, E.13
Cascieri, M.A.14
Metzger, J.15
MacIntyre, D.16
Williamson, D.17
Iversen, L.18
Hill, R.G.19
-
26
-
-
0030911476
-
1 receptor antagonists
-
1 receptor antagonists. Eur. J. Pharmacol. 1996, 326 (2/3), 201-209.
-
(1996)
Eur. J. Pharmacol.
, vol.326
, Issue.2-3
, pp. 201-209
-
-
Rupniak, N.M.J.1
Tattersall, F.D.2
Williams, A.R.3
Rycroft, W.4
Carlson, E.5
Cascieri, M.A.6
Sadowski, S.7
Ber, E.8
Hale, J.9
Mills, S.G.10
MacCoss, M.11
Seward, E.M.12
Huscroft, I.13
Owen, S.14
Swain, C.J.15
Hill, R.16
Hargreaves, R.J.17
-
28
-
-
0028123558
-
Cardiovascular Effects of CP-96,345, A Non-Peptide Blocker of Tachykinin Receptors
-
(b) Constantine, J. W.; Lebel, W. S.; Woody, H. A.; Benoit, P. A.; Woolfgang, E. A.; Knight, D. R. Cardiovascular Effects of CP-96,345, A Non-Peptide Blocker of Tachykinin Receptors. Eur. J. Pharmacol. 1994, 252, 275-282.
-
(1994)
Eur. J. Pharmacol.
, vol.252
, pp. 275-282
-
-
Constantine, J.W.1
Lebel, W.S.2
Woody, H.A.3
Benoit, P.A.4
Woolfgang, E.A.5
Knight, D.R.6
-
29
-
-
0028821240
-
1 antagonists 2: Investigation of the Effect of N-substitution
-
1 antagonists 2: Investigation of the Effect of N-substitution. Bioorg. Med. Chem. Lett. 1995, 5, 209-212.
-
(1995)
Bioorg. Med. Chem. Lett.
, vol.5
, pp. 209-212
-
-
Harrison, T.1
Owens, A.P.2
Williams, B.J.3
Swain, C.J.4
Baker, R.5
Hutson, P.H.6
Sadowski, S.7
Cascieri, M.A.8
-
30
-
-
15444342580
-
-
PCT WO93/04040, 1993
-
(d) Baker, R.; Harrison, T.; Swain, C. J.; Williams, B. J. PCT WO93/04040, 1993.
-
-
-
Baker, R.1
Harrison, T.2
Swain, C.J.3
Williams, B.J.4
-
31
-
-
0028922834
-
1 Antagonist
-
1 Antagonist. J. Med. Chem. 1995, 38, 1264-1266.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 1264-1266
-
-
Stevenson, G.I.1
MacLeod, A.M.2
Huscroft, I.3
Cascieri, M.A.4
Sadowski, S.5
Baker, R.6
-
32
-
-
0027157571
-
1 Antagonists I: 3-Benzyloxy-1-azabicyclo-[2.2.2]octanes
-
1 Antagonists I: 3-Benzyloxy-1-azabicyclo-[2.2.2]octanes. Bioorg. Med. Chem. Lett. 1993, 3 (6), 1361-1366.
-
(1993)
Bioorg. Med. Chem. Lett.
, vol.3
, Issue.6
, pp. 1361-1366
-
-
Seward, E.M.1
Swain, C.J.2
Merchant, K.J.3
Owen, S.N.4
Sabin, V.5
Cascieri, M.A.6
Sadowski, S.7
Strader, C.D.8
Baker, R.9
-
33
-
-
0027959361
-
1 Antagonists: Replacements for the Benzhydryl Group
-
1 Antagonists: Replacements for the Benzhydryl Group. Bioorg. Med. Chem. Lett. 1994, 4 (18), 2161-2164.
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, Issue.18
, pp. 2161-2164
-
-
Swain, C.J.1
Cascieri, M.A.2
Owens, A.P.3
Saari, W.4
Sadowski, S.5
Strader, C.D.6
Teall, M.7
Van Niel, M.B.8
Williams, B.J.9
-
34
-
-
0028104822
-
Gem-Disubstituted Amino-Ether Based Substance P Antagonists
-
Harrison, T.; Williams, B. J.; Swain, C. J. Gem-Disubstituted Amino-Ether Based Substance P Antagonists. Bioorg. Med. Chem. Lett. 1994, 4, 2733-2734.
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, pp. 2733-2734
-
-
Harrison, T.1
Williams, B.J.2
Swain, C.J.3
-
35
-
-
0027065565
-
Characterisation of the Binding of a Potent, Selective Radio-iodinated Antagonist to the Human Neurokinin-1 Receptor
-
Cascieri, M. A.; Ber, E.; Fong, T. M.; Sadowski, S.; Bansal, A.; Swain, C. J.; Seward, E. M.; Frances, B.; Burns, D.; Strader, C. D. Characterisation of the Binding of a Potent, Selective Radio-iodinated Antagonist to the Human Neurokinin-1 Receptor. Mol. Pharmacol. 1992, 42, 458-463.
-
(1992)
Mol. Pharmacol.
, vol.42
, pp. 458-463
-
-
Cascieri, M.A.1
Ber, E.2
Fong, T.M.3
Sadowski, S.4
Bansal, A.5
Swain, C.J.6
Seward, E.M.7
Frances, B.8
Burns, D.9
Strader, C.D.10
-
36
-
-
0001755988
-
Stereochemical aspects of drug action I: Conformational restriction, steric hindrance and hydrophobic collapse
-
Hart, P. A.; Rich, D. Stereochemical aspects of drug action I: Conformational restriction, steric hindrance and hydrophobic collapse. Pract. Med. Chem. 1996, 393-412.
-
(1996)
Pract. Med. Chem.
, pp. 393-412
-
-
Hart, P.A.1
Rich, D.2
-
37
-
-
0028790133
-
Mutational analysis of neurokinin receptor function
-
Fong, T. M.; Huang, R. R.; Yu, H.; Swain, C. J.; Underwood, D.; Cascieri, M. A.; Strader, C. D. Mutational analysis of neurokinin receptor function. Can. J. Physiol. Pharmacol. 1995, 73 (7), 860-5.
-
(1995)
Can. J. Physiol. Pharmacol.
, vol.73
, Issue.7
, pp. 860-865
-
-
Fong, T.M.1
Huang, R.R.2
Yu, H.3
Swain, C.J.4
Underwood, D.5
Cascieri, M.A.6
Strader, C.D.7
-
38
-
-
0026728135
-
1) Antagonist, CP-96,345
-
1) Antagonist, CP-96,345. Bioorg. Med. Chem. Lett. 1992, 2, 559-564.
-
(1992)
Bioorg. Med. Chem. Lett.
, vol.2
, pp. 559-564
-
-
Howson, W.1
Hodgson, J.2
Richardson, R.3
Walten, W.4
Guard, S.5
Watling, K.6
-
39
-
-
0030299823
-
1 Receptor Antagonists Act Centrally to Inhibit Emesis Induced by the Chemotherapeutic Agent Cisplatin in Ferrets
-
1 Receptor Antagonists Act Centrally to Inhibit Emesis Induced by the Chemotherapeutic Agent Cisplatin in Ferrets. Neuropharmacology 1996, 35 (8), 1121-1129.
-
(1996)
Neuropharmacology
, vol.35
, Issue.8
, pp. 1121-1129
-
-
Tattersall, F.D.1
Rycroft, W.2
Francis, B.3
Pearce, D.4
Merchant, K.5
MacLeod, A.M.M.6
Ladduwahetty, T.7
Keown, L.8
Swain, C.J.9
Baker, R.10
Cascieri, M.A.11
Ber, E.12
Metzger, J.13
MacIntyre, D.E.14
Hill, R.G.15
Hargreaves, R.J.16
|